PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsGallium
Gallium
Ganite (gallium) is a small molecule pharmaceutical. Gallium was first approved as Ganite on 1991-01-17. It is used to treat positron-emission tomography in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
diagnosisD003933
Trade Name
FDA
EMA
Gallium ga, Gallium ga 68 edotreotide, Gallium ga 68 gozetotide, Illuccix, Locametz, Netspot (discontinued: Gallium ga, Ganite, Neoscan)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Gallium citrate ga-67
Tradename
Company
Number
Date
Products
GALLIUM CITRATE GA 67CuriumN-018058 RX1982-01-01
1 products
Show 3 discontinued
Gallium nitrate
Tradename
Company
Number
Date
Products
GANITEGentaN-019961 DISCN1991-01-17
1 products
Hide discontinued
Gallium ga-68 gozetotide
Tradename
Company
Number
Date
Products
LOCAMETZNovartisN-215841 RX2022-03-23
1 products, RLD, RS
ILLUCCIXTelixN-214032 RX2021-12-17
1 products, RLD, RS
GALLIUM GA 68 GOZETOTIDEUCLAN-212642 RX2020-12-01
1 products, RLD, RS
GALLIUM GA 68 GOZETOTIDEUCSFN-212643 RX2020-12-01
1 products, RLD, RS
Gallium dotatate ga-68
Tradename
Company
Number
Date
Products
NETSPOTAdvanced Accelerator ApplicationsN-208547 RX2016-06-01
1 products, RLD, RS
Gallium ga-68 edotreotide
Tradename
Company
Number
Date
Products
GALLIUM GA 68 EDOTREOTIDEUniversity of IowaN-210828 RX2019-08-21
1 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
ga-68-dotatocNew Drug Application2021-12-08
gallium citrate ga-67New Drug Application2024-05-10
gallium ga-68 psma-11New Drug Application2025-01-01
ganiteNew Drug Application2012-03-19
illuccixNew Drug Application2024-09-24
locametzNew Drug Application2024-07-09
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
positron-emission tomography—D049268—
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
V: Various drug classes in atc
— V09: Diagnostic radiopharmaceuticals
— V09H: Inflammation and infection detection
— V09HX: Other diagnostic radiopharmaceuticals for inflammation and infection detection in atc
— V09HX01: Gallium (67ga) citrate
— V09I: Tumour detection radiopharmaceuticals
— V09IX: Other diagnostic radiopharmaceuticals for tumour detection in atc
— V09IX09: Gallium (68ga) edotreotide
— V09IX14: Gallium (68ga) gozetotide
HCPCS
Code
Description
A9556
Gallium ga-67 citrate, diagnostic, per millicurie
A9587
Gallium ga-68, dotatate, diagnostic, 0.1 millicurie
A9593
Gallium ga-68 psma-11, diagnostic, (ucsf), 1 millicurie
A9594
Gallium ga-68 psma-11, diagnostic, (ucla), 1 millicurie
A9596
Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie
A9800
Gallium ga-68 gozetotide, diagnostic, (locametz), 1 millicurie
C9067
Gallium ga-68, dotatoc, diagnostic, 0.01 mci
J1457
Injection, gallium nitrate, 1 mg
Clinical
Clinical Trials
298 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Prostatic neoplasmsD011471—C6111——12
NeoplasmsD009369—C8011———1
Indications Phases 1
No data
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Castration-resistant prostatic neoplasmsD064129——————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameGallium
INNgallium (67ga) citrate
Description
Ganite (gallium) is a small molecule pharmaceutical. Gallium was first approved as Ganite on 1991-01-17.
Classification
Small molecule
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID7440-55-3
RxCUI—
ChEMBL IDCHEMBL1201200
ChEBI ID49631
PubChem CID—
DrugBank—
UNII ID4LJK511Z86 (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 30,746 documents
View more details
Safety
Black-box Warning
Black-box warning for: Ganite
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
375 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use